Lunai (LNAI) news
Recent news
Lunai Bioworks - Second amended complaint alleges securities fraud and market manipulation under rule 10B-5
AInvest Wire · 4d agoLunai Bioworks - Files second amended complaint naming six broker-dealers and two principals
Lunai Bioworks, Inc. (Nasdaq: LNAI) has filed a Second Amended Complaint in the United States District Court for the District of Delaware, naming six broker-dealers and two principals in its ongoing litigation. The lawsuit, initially filed in May 2026, alleges a coordinated naked short-selling…
AInvest Wire · 4d agoLunai Bioworks (NASDAQ: LNAI) signs definitive collaboration agreement with Brainstorm Therapeutics; initial Parkinson's disease data readout targeted for first half of 2027
Lunai Bioworks (NASDAQ: LNAI) has signed a definitive collaboration agreement with Brainstorm Therapeutics, marking a strategic step in its Parkinson’s disease research and drug discovery initiatives. The partnership builds on an earlier letter of intent and aims to leverage combined strengths in…
AInvest Wire · Aug 4, 2026Lunai Bioworks - regains Nasdaq compliance with minimum $1 bid price rule - SEC filing
Lunai Bioworks, Inc. (NASDAQ: LNAI) announced on October 16, 2025, that it had regained Nasdaq minimum bid price compliance . On April 14, 2025, Nasdaq staff notified the company that its stock had failed to maintain a minimum bid price of $1.00 for the prior 30 business days. However, the…
AInvest Wire · Jun 16, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.